SCHEMBL32689014

SCHEMBL32689014

CC(=O)CCC(=O)C1CC2C=CC1C2

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.49
LMNA P02545 2/20 0.49
ALDH1A1 P00352 5/20 0.37
RAB9A P51151 1/20 0.36
THRB P10828 1/20 0.36
HPGD P15428 1/20 0.35
EPHX2 P34913 3/20 0.35
KMT2A Q03164 2/20 0.34
POLB P06746 2/20 0.34
APEX1 P27695 1/20 0.33
RECQL P46063 1/20 0.33
BLM P54132 1/20 0.33
ESR2 Q92731 1/20 0.33
HSD17B10 Q99714 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
SLC15A2 Q16348 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32688754 0.90 KDM4E (0.46) KDM4ELMNAALDH1A1RAB9ATHRB
SCHEMBL13346338 0.84 KDM4E (0.50) KDM4ELMNAALDH1A1RAB9ATHRB
SCHEMBL32689204 0.84 KDM4E (0.55) KDM4ELMNAALDH1A1RAB9ATHRB
SCHEMBL32689208 0.83 KDM4E (0.46) KDM4ELMNAALDH1A1RAB9ATHRB
SCHEMBL32688765 0.81 KDM4E (0.45) KDM4ELMNAALDH1A1RAB9ATHRB
SCHEMBL32688618 0.81 KDM4E (0.45) KDM4ELMNAALDH1A1RAB9ATHRB
SCHEMBL13346339 0.81 LMNA (0.47) KDM4ELMNAALDH1A1RAB9ATHRB
SCHEMBL4741806 0.79 KDM4E (0.53) KDM4ELMNAALDH1A1RAB9ATHRB
SCHEMBL17165985 0.79 KDM4E (0.46) KDM4ELMNAALDH1A1RAB9ATHRB
SCHEMBL12798525 0.79 KDM4E (0.46) KDM4ELMNAALDH1A1RAB9ATHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260078079-A1 FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING NORBORNANE AND NORBORNENE DERIVATIVES OSMO LABS PBC (US) 2026-03-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260078079-A1 FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING NORBORNANE AND NORBORNENE DERIVATIVES CBR1, CBR3, TAS2R1 KDM4E 4643/4885LMNA 2153/4885ALDH1A1 804/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.